Last $0.0045 USD
Change Today -0.001 / -18.18%
Volume 2.1K
PPCH On Other Exchanges
Symbol
Exchange
OTC US
As of 11:13 AM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

propanc health group corp (PPCH) Snapshot

Open
$0.0045
Previous Close
$0.0055
Day High
$0.0045
Day Low
$0.0045
52 Week High
05/22/14 - $0.47
52 Week Low
10/28/14 - $0.0040
Market Cap
371.0K
Average Volume 10 Days
372.6K
EPS TTM
--
Shares Outstanding
82.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PROPANC HEALTH GROUP CORP (PPCH)

Related News

No related news articles were found.

propanc health group corp (PPCH) Related Businessweek News

No Related Businessweek News Found

propanc health group corp (PPCH) Details

Propanc Health Group Corporation, a development stage healthcare company, focuses on the development of cancer treatments for patients with pancreatic and colorectal cancer. The company’s lead product includes PRP, a patented formulation consisting of two pro-enzymes, such as trypsinogen and chymotrypsinogen, as well as the enzyme amylase designed to synergistically enhance anti-cancer effects. It is also developing a combination of anti-cancer agents working in combination with pro-enzymes, which enhance PRP’s anti-cancer effects. The company was formerly known as Propanc PTY LTD. Propanc Health Group Corporation was founded in 2007 and is based in Melbourne, Australia.

propanc health group corp (PPCH) Top Compensated Officers

Chief Executive officer, Chief Financial offi...
Total Annual Compensation: $137.7K
Acting Chief Medical Officer and Member of Sc...
Total Annual Compensation: $7.9K
Compensation as of Fiscal Year 2014.

propanc health group corp (PPCH) Key Developments

Propanc Health Group Corporation expected to report Fiscal Year 2014 results on October 31, 2014. This event was calculated by Capital IQ (Created on October 25, 2014).

Propanc Health Group Corporation expected to report Fiscal Year 2014 results on October 31, 2014. This event was calculated by Capital IQ (Created on October 25, 2014).

Propanc Health Group Corporation Auditor Raises 'Going Concern' Doubt

Propanc Health Group Corporation filed its 10-K on Oct 14, 2014 for the period ending Jun 30, 2014. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Propanc Health Group Corporation announced delayed annual 10-K filing

On 09/29/2014, Propanc Health Group Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPCH:US $0.00 USD -0.001

PPCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PPCH.
View Industry Companies
 

Industry Analysis

PPCH

Industry Average

Valuation PPCH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROPANC HEALTH GROUP CORP, please visit www.propanc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.